APRIL 6, 2026 AT 11:01 AM

Neurocrine confirms it is to acquire Soleno Therapeutics (SLNO) for USD 53/shr in cash or USD 2.9bln

Importance

Level 1

#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#FOREX#METALS#EU SESSION#US SESSION#METALS & MINING#DXY#US EQUITIES